Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QS01E<br />
ANTIGLAUCOMA PREPARATIONS AND MIOTICS<br />
Preparations for local and systemic treatment of glaucoma should be classified in<br />
this group. Drugs used for producing miosis are classified in this group, even if the<br />
main indication is not glaucoma.<br />
QS01EA<br />
Sympathomimetics in glaucoma therapy<br />
Preparations containing epinephrine and pilocarpine in combination are classified<br />
in QS01EB - Parasympathomimetics.<br />
QS01EB<br />
QS01EC<br />
QS01ED<br />
Parasympathomimetics<br />
Carbonic anhydrase inhibitors<br />
Beta blocking agents<br />
Combinations of beta blocking agents and other substances, e.g. pilocarpine, are<br />
classified in this group, in separate 5th level groups using the corresponding<br />
50-series codes or, if not available, using the ATCvet 5th level code 99.<br />
QS01EE<br />
QS01EX<br />
Prostaglandin analogues<br />
Other antiglaucoma preparations<br />
QS01F<br />
QS01FA<br />
MYDRIATICS AND CYCLOPLEGICS<br />
Anticholinergics<br />
Combinations with sympathomimetics are classified in this group.<br />
Combinations with corticosteroids are classified in QS01BB - Corticosteroids and<br />
mydriatics in combination.<br />
QS01FB<br />
Sympathomimetics, excl. antiglaucoma preparations<br />
Phenylephrine at high strengths is classified in this group, see also QS01GA -<br />
Sympathomimetics used as decongestants. Sympathomimetics used in glaucoma<br />
therapy, see QS01EA.<br />
170
Change language